Morgan Stanley (MS)

Retained Earnings

$122.77B

Quarterly · Period ending: · USD

MS logo

MS Retained Earnings

Latest reported$122.77B
MS Quarterly Retained Earnings ($281.80M → $122.77B)
High-resolution chart · PNG

MS retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Morgan Stanley Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
122,774,000,000
118,913,000,000
115,091,000,000
112,426,000,000
109,567,000,000
107,653,000,000
104,989,000,000
102,911,000,000
101,374,000,000
99,811,000,000
97,996,000,000
98,007,000,000
97,151,000,000
96,392,000,000
94,862,000,000
94,055,000,000
92,889,000,000
91,722,000,000
89,432,000,000
87,099,000,000
84,791,000,000
82,034,000,000
78,694,000,000
76,061,000,000
74,015,000,000
71,518,000,000
70,589,000,000
69,071,000,000
67,588,000,000
66,061,000,000
64,175,000,000
63,330,000,000
61,835,000,000
60,009,000,000
57,577,000,000
57,554,000,000
56,325,000,000
55,109,000,000
53,679,000,000
52,545,000,000
51,410,000,000
50,272,000,000
49,204,000,000
48,746,000,000
48,106,000,000
46,740,000,000
44,625,000,000
46,573,000,000
45,145,000,000
43,522,000,000
42,172,000,000
42,237,000,000
41,455,000,000
40,750,000,000
39,912,000,000
39,441,000,000
40,586,000,000
40,118,000,000
40,341,000,000
40,710,000,000
38,637,000,000
39,269,000,000
38,603,000,000
38,056,000,000
38,210,000,000
36,539,000,000
35,056,000,000
34,726,000,000
34,245,000,000
35,577,000,000
38,096,000,000
40,698,000,000
39,581,000,000
38,852,000,000
38,045,000,000
42,043,000,000
46,256,000,000
43,975,000,000
41,422,000,000
39,519,000,000
38,125,000,000
36,456,000,000
35,185,000,000
33,011,000,000
33,160,000,000
32,527,000,000
31,426,000,000
30,500,000,000
29,938,000,000
28,990,000,000
28,038,000,000
27,270,000,000
26,251,000,000
25,901,000,000
25,250,000,000
24,768,000,000
24,408,000,000
23,865,000,000
23,270,000,000
22,657,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.